These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22103568)

  • 1. Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders, assessed by liver stiffness measurements.
    Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Biesma DH; Mauser-Bunschoten EP
    Haemophilia; 2012 May; 18(3):e266-72. PubMed ID: 22103568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders.
    Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Mauser-Bunschoten EP
    Haemophilia; 2011 Sep; 17(5):e975-80. PubMed ID: 21535322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice.
    Fransen van de Putte D; Blom R; van Soest H; Mundt M; Verveer C; Arends J; de Knegt RE; Mauser-Bunschoten E; van Erpecum K
    Ann Hepatol; 2011; 10(4):469-76. PubMed ID: 21911887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.
    Petta S; Cammà C; DI Marco V; Calvaruso V; Enea M; Bronte F; Butera G; Cabibi D; Craxì A
    Aliment Pharmacol Ther; 2009 Sep; 30(6):603-13. PubMed ID: 19563503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outreach screening of drug users for cirrhosis with transient elastography.
    Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
    Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chu SH; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2011; 16(2):165-72. PubMed ID: 21447865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.
    Macías J; Camacho A; Von Wichmann MA; López-Cortés LF; Ortega E; Tural C; Ríos MJ; Merino D; Téllez F; Márquez M; Mancebo M; Pineda JA
    AIDS; 2013 Oct; 27(16):2541-9. PubMed ID: 23736148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.
    Fransen van de Putte DE; Makris M; Fischer K; Yee TT; Kirk L; van Erpecum KJ; Patch D; Posthouwer D; Mauser-Bunschoten EP
    J Hepatol; 2014 Jan; 60(1):39-45. PubMed ID: 23978717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previously unrecognized advanced liver disease unveiled by transient elastography in patients with Haemophilia and chronic hepatitis C.
    Moessner BK; Andersen ES; Weis N; Laursen AL; Ingerslev J; Lethagen S; Pedersen C; Christensen PB
    Haemophilia; 2011 Nov; 17(6):938-43. PubMed ID: 21435119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
    Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
    Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
    Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.
    Fung J; Lai CL; Wong DK; Seto WK; Hung I; Yuen MF
    J Viral Hepat; 2011 Jul; 18(7):e200-5. PubMed ID: 21692933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C.
    van Santen DK; Agius PA; Sasadeusz J; Fairley CK; Sievert W; Gane E; Iser D; O'Reilly M; Medland NA; Moore R; Hellard ME; Hoy JF; Doyle JS;
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):e81-e89. PubMed ID: 32842055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
    Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M
    Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
    Carrión JA; Torres F; Crespo G; Miquel R; García-Valdecasas JC; Navasa M; Forns X
    Hepatology; 2010 Jan; 51(1):23-34. PubMed ID: 19839063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.
    Marcellin P; Ziol M; Bedossa P; Douvin C; Poupon R; de Lédinghen V; Beaugrand M
    Liver Int; 2009 Feb; 29(2):242-7. PubMed ID: 18637064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.